Filing Details
- Accession Number:
- 0001396677-13-000041
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-12 17:43:31
- Reporting Period:
- 2013-06-10
- Filing Date:
- 2013-06-12
- Accepted Time:
- 2013-06-12 17:43:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1050007 | Nutraceutical International Corp | NUTR | Medicinal Chemicals & Botanical Products (2833) | 870515089 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1079725 | Ii W Frank Gay | Nutracetical International Corp 1400 Kearns Blvd 2Nd Fl. Park City UT 84060 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-12-27 | 10,000 | $0.00 | 733,399 | No | 5 | G | Direct | |
Common Stock | Acquisiton | 2013-02-08 | 120 | $0.00 | 120 | No | 5 | W | Indirect | By spouse |
Common Stock | Acquisiton | 2013-06-10 | 12,060 | $12.32 | 745,459 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-06-10 | 12,060 | $20.12 | 733,399 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-06-11 | 3,048 | $12.32 | 736,447 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-06-11 | 3,048 | $20.24 | 733,399 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-06-12 | 1,050 | $12.32 | 734,449 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-06-12 | 1,050 | $20.06 | 733,399 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 5 | W | Indirect | By spouse |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-06-10 | 12,060 | $0.00 | 12,060 | $12.32 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-06-11 | 3,048 | $0.00 | 3,048 | $12.32 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-06-12 | 1,050 | $0.00 | 1,050 | $12.32 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
47,940 | 2013-12-17 | No | 4 | M | Direct | |
44,892 | 2013-12-17 | No | 4 | M | Direct | |
43,842 | 2013-12-17 | No | 4 | M | Direct |
Footnotes
- Shares inherited by spouse from settlement of spouse's mother's estate.
- The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- Exercise of options expiring on December 17, 2013.
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 7, 2013.
- The price shown in Column 4 is a weighted average sale price. The price range for the sales is $20.0000 to $20.5650. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The price shown in Column 4 is a weighted average sale price. The price range for the sales is $20.0000 to $20.4800. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The price shown in Column 4 is a weighted average sale price. The price range for the sales is $20.0000 to $20.1300. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The option vested in six equal installments every six months beginning on June 17, 2004.